Cargando…
First do no harm: surrogate endpoints and the lesson of β-agonists in acute lung injury
EXPANDED ABSTRACT: CITATION: Matthay MA, Brower RG, Carson S, Douglas IS, Eisner M, Hite D, Holets S, Kallet RH, Liu KD, MacIntyre N, Moss M, Schoenfeld D, Steingrub J, Thompson BT: Randomized, placebo-controlled clinical trial of an aerosolized β-agonist for treatment of acute lung injury. National...
Autores principales: | Lakshminarayana, Pradeep H, Kahn, Jeremy M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580665/ https://www.ncbi.nlm.nih.gov/pubmed/22731873 http://dx.doi.org/10.1186/CC11392 |
Ejemplares similares
-
Implementing evidence-based practice in the neuroscience intensive care unit
por: Elmer, Jonathan, et al.
Publicado: (2014) -
Beyond checklists: Using clinician prompts to achieve meaningful ICU quality improvement
por: Idahosa, Osamudiamen, et al.
Publicado: (2012) -
Making the GRADE: how useful are the new Surviving Sepsis Campaign guidelines?
por: Vo, Mai, et al.
Publicado: (2013) -
Does space make waste? The influence of ICU bed capacity on admission
decisions
por: Mery, Esteban, et al.
Publicado: (2013) -
New obstacles to improving the quality of end-of-life care in ICU
por: Bocharov, Maxim V, et al.
Publicado: (2012)